Dr. Maria Simonenko, Russian Federation
The first experience of Inclisiran treatment after heart transplantation

Dr. Nadezhda Koloskova, Russian Federation
Long-term experience of outpatient follow-up after heart transplant at Shumakov center

Dr. Ronaldo H B Santos, Brazil
Use Of The lntra-Aortic Balloon Pump As A Bridge To Transplant: Still A Very Good Option - 10 Years Of Experience ln The Largest Heart Transplant Center ln Brazil

Dr. Ronaldo H B Santos, Brazil
The Importance of a Brazilian Specialized Transplant Center in a High-Complexity University Hospital: an 11 years overview of the outcomes.

Dr. Ronaldo H B Santos, Brazil
The Suicide Heart: Primary Graft Dysfunction and Mortality after Heart Transplantation

Dr. Nadezhda Koloskova, Russian Federation
Multimorbidity and complexity of treatment in the long term after heart transplantation.

Dr. Ronaldo H B Santos, Brazil
Donor and Recipient Risk Assessment in Heart Transplantation at a Reference Center in Latin America and Its Influence on Clinical Outcomes.

Dr. Murat Ozkan, Turkey
Heart transplantation in pediatric patients with restrictive cardiomyopathy

Dr. Deniz Sarp Beyazpinar, Turkey
Comparison of normal and low preoperative right ventricular function in terms of acute renal failure in patients implanted with a left ventricular assist device

Dr. Begum Yavascaoglu Uney, Turkey
A study in heart transplant patients: Especially class-II anti-HLA antibodies may remain persistent

Graciela Svetliza, Argentina
Malignancy after lung transplantation

Graciela Svetliza, Argentina
Pregnancy in lung transplant recipients

Dr. Mohamed Elrefaei, United States
Clinical utility of 1:16 serum dilution as a predictor of response to therapeutic plasma exchange for HLA antibody-mediated rejection treatment and overall survival in lung transplant recipients: A two center study

Dr. Renata Ponsirenas, United States
Correlation of pre and immediate post-transplant factors with initial dd-cfDNA% in patients in a surveillance protocol

Dr. Renata Ponsirenas, United States
Evaluation of Donor-Derived Cell-Free DNA (dd-cfDNA) levels in Primary Graft Dysfunction (PGD) After Lung Transplantation